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M. avium subspecies paratuberculosis, hereafter referred to as
MAP, is a significant veterinary pathogen that causes Johne’s dis-
ease in ruminants, including cattle, sheep, and goats. This chronic
intestinal disease is distributed worldwide and exacts a heavy eco-
nomic toll on animal producers. For example, the dairy industry
incurs substantial economic losses due to reduced milk produc-
tion, premature culling, and reduced slaughter value (Raizman
et al., 2009). It takes years for clinical signs to appear in animals
after initial infection. The bacterium is shed in high numbers in
the feces during this clinical phase of disease. Transmission is by
ingestion of the bacterium while grazing on pastures contami-
nated by this shedding process. Milk, passed from the infected
dam to the daughter, has also been shown as a transmission
route (Stabel, 2008). To best combat this chronic infection, vac-
cination has the promise to reduce economic losses and control
Johne’s disease. In the conception of this eBook for Frontiers
in Cellular and Infection Microbiology, we solicited commu-
nications describing technologies and approaches to immunize
animals against Johne’s disease.
Among the first large-scale vaccine trials for Johne’s disease
began in the early 1990s using killed whole cells in oil injected
into cattle (Kormendy, 1994; Wentink et al., 1994). Those trials
showed vaccination was useful to reduce shedding of the bacteria
in the feces, thus potentially reducing cow-to-calf transmission,
but was ineffective at preventing infection. Since that time, exper-
iments have evaluated extracts of the bacteria and live cells in all
hosts including sheep, goats, deer, and cattle. Furthermore, the
strain of MAP used has varied greatly in those studies. Then in
2007, an effort wasmade to standardize the challengemodels used
to test new vaccines for combating Johne’s disease (Hines et al.,
2007). The parameters outlined for the goat model in that arti-
cle were used to test the best available live attenuated candidates
(Hines et al., 2014) as described in this eBook compilation.
The genome sequence and re-sequence of MAP (Li et al.,
2005; Wynne et al., 2010) has greatly expanded our knowl-
edge about proteins predicted to be located in the mycobac-
terial envelope through annotation and bioinformatic analyses.
Even now, most of what is known can be obtained only from
annotation predictions and computer modeling algorithms that
suggest protein locations within a cell (Yu et al., 2010). A per-
fect example of the power of genomics was demonstrated a few
years later when libraries of transposon mutants and transcrip-
tomic studies were reported by several groups working with
MAP (Shin et al., 2006; Wu et al., 2006, 2007; Janagama et al.,
2010). Furthermore, genomics provided an important resource
for targeted construction of live-attenuated vaccine (LAV) can-
didates, which is the focus of several articles in this eBook. It is
noteworthy that despite a focus on LAV strategies, we do not dis-
count efforts directed toward the development of other vaccine
technologies such as subunit or vectored vaccines (Hoek et al.,
2010; Faisal et al., 2013; Thakur et al., 2013). Although these tech-
nologies are still under development, they could provide effective
vaccines in the future.
Live attenuated vaccine strains of MAP are thought to
be the best approach for vaccination against Johne’s disease.
Although traditional inactivated and LAV candidates cannot sat-
isfy the DIVA approach, they will completely stimulate both
cell-mediated and humoral immune responses (Park et al., 2011;
Faisal et al., 2013). Numerous studies have suggested the role of
cell-mediated immunity to provide protective responses against
MAP infection, as suggested before in both the murine (Ghosh
et al., 2014; Settles et al., 2014) and bovine models (Stabel
et al., 2011) of Johne’s disease. A partial analysis of the gener-
ated immune responses following immunization with novel LAV
candidates is reported in this eBook (Hines et al., 2014) as part
of a large scale vaccine trial. Additional analyses on the T cell
populations and specific antigens detected will be forthcoming
(Bannantine et al., unpublished).
To summarize the contributions to this research topic, the
opening article reviews efforts by the Johne’s disease research
community to test available LAV strains of MAP through a series
of three gated trials (Bannantine et al., 2014b). This trial series
has been a coordinated international, multi-institutional effort
that spanned several years. Many new ideas and retrospective
approaches have emerged from this unprecedented effort. These
aspects have been captured in this research topic. Details sur-
rounding the construction of the attenuated mutants are also
included as well as a list of the lessons learned from this inte-
grated study. The next two articles describe a knockout mutant
of relA (Park et al., 2014) and a library of transposon mutants
(Rathnaiah et al., 2014). Both approaches are useful for gener-
ating live attenuated strains. The next three articles (Bannantine
et al., 2014a; Hines et al., 2014; Lamont et al., 2014) describe
in detail the three phases of the vaccine project summarized in
the opening article. The remaining articles highlight immuno-
logical evaluation of subunit vaccines (Gurung et al., 2014), pro-
duction of subunit vaccines using heterologous hosts (Johnston
et al., 2014) and finally, take a unique look at the importance
of post-translational modifications for vaccine design, with a
highlight on glycoproteins (Facciuolo and Mutharia, 2014).
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